Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Central Nervous System Neoplasms 4Oligodendroglioma 2Brain Neoplasms 2Astrocytoma 2Neuroblastoma 1Gliosarcoma 1Glioma 1Glioblastoma 1

Interventions

Temozolomide 163Radiosurgery 129Radiotherapy 107Bevacizumab 98Magnetic Resonance Spectroscopy 75Carboplatin 48Surgical Procedures, Operative 35pembrolizumab 34Radiation 34Etoposide 34Nivolumab 33Irinotecan 33Cyclophosphamide 33Erlotinib Hydrochloride 31Carmustine 28Lomustine 26Trastuzumab 25Cisplatin 25Ipilimumab 24Filgrastim 23Mental Status and Dementia Tests 21Magnetic Resonance Imaging 21Aminolevulinic Acid 21Vincristine 20Surveys and Questionnaires 19Capecitabine 19Topotecan 18Specimen Handling 18Pemetrexed 18Radiotherapy, Intensity-Modulated 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Brain Neoplasms × In Situ Hybridization, Fluorescence × CNS × Clear all
NCT00003096 2014-08-06

Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors

Children's Oncology Group

Completed
88 enrolled
CNS

Brain Neoplasms, Central Nervous System Neoplasms

NCT00424060 2012-09-24

Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
38 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡